Pituitary stalk interruption syndrome
Open Access
- 11 December 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (50) , e23266
Abstract
Rationale: Pituitary stalk interruption syndrome (PSIS) is a congenital pituitary anatomical defect. It is characterized by the triad of thin or interrupted pituitary stalk, absent or ectopic posterior lobe, and hypoplastic or aplastic anterior lobe. Moreover, this condition is considered rare. Patient concerns: A 23-year-old male patient presented with a history of short stature and hypogonadism. Laboratory assessment revealed low thyroxine, cortisol, and adrenocorticotropic hormone levels, which are consistent with adrenal insufficiency without hypoglycemia. The insulin-induced hypoglycemia tolerance test finding indicated growth hormone (GH) deficiency. Moreover, magnetic resonance imaging revealed an interrupted pituitary stalk, ectopic posterior pituitary, and hypoplastic anterior pituitary. This triad of symptoms was indicative of PSIS. Diagnosis: Interventions: The patient was deficient in adrenaline, thyroxine, gonadal steroid, and GH. Thus, glucocorticoid replacement therapy was initiated, followed by euthyrox, androgen, and human chorionic gonadotropin treatment. Calcium tablets, calcitriol, and alendronate sodium were used for the management of osteoporosis. The patient was 164 cm tall, and his bone age was approximately 15 years old. However, owing to a poor economic condition, the family did not proceed with GH therapy. Outcomes: The patient did not present with adrenal or hypothyroidism crisis after receiving poly-hormonal replacement therapy. His secondary sexual characteristics began to develop. However, owing to a short treatment window period, the patient could not receive the required treatment. Hence, whether the patient would have a normal fertility function needs to be confirmed. Lessons: PSIS is a rare disease with various clinical characteristics. During the neonatal period and infancy, the signs and symptoms of PSIS are often not evident. Therefore, diagnosis is delayed. The early detection of hormone deficiency and treatment initiation can affect both the quality of life and the prognosis of patients with PSIS. Thus, the diagnosis and treatment of this disease must be improved to help patients achieve a better quality of life and to prevent reproductive health problems.Keywords
Funding Information
- Applied Basic Research Foundation of Yunnan Province (2018FE001 (-100))
This publication has 19 references indexed in Scilit:
- DIAGNOSIS OF ENDOCRINE DISEASE: Pituitary stalk interruption syndrome: etiology and clinical manifestationsEuropean Journal of Endocrinology, 2019
- Pituitary stalk interruption syndromeBMJ Case Reports, 2019
- Addison-Krise – Risiko erkennen und rasch behandelnDMW - Deutsche Medizinische Wochenschrift, 2018
- Growth without growth hormone in combined pituitary hormone deficiency caused by pituitary stalk interruption syndromeAnnals of Pediatric Endocrinology & Metabolism, 2017
- Pituitary Stalk Interruption Syndrome: From Clinical Findings to PathogenesisJournal of Neuroendocrinology, 2016
- Growth Hormone-Insulin-Like Growth Factor Axis, Thyroid Axis, Prolactin, and Exercise2016
- Pituitary stalk interruption syndrome in 58 Chinese patients: clinical features and genetic analysisClinical Endocrinology, 2012
- Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative formsEuropean Journal of Endocrinology, 2011
- Leptin Inhibits Osteoclast GenerationJournal of Bone and Mineral Research, 2002
- Transection of the pituitary stalk: development of an ectopic posterior lobe assessed with MR imaging.Radiology, 1987